Zhengye Biotechnology Holding Ltd

Zhengye Biotechnology Holding Ltd (ZYBT) priced its initial public offering on Jan 7, 2025 at $4.00 per share, within its $4.00–$5.00 range, raising $6M, and listed on Nasdaq. At the IPO price its market capitalization was about $188.7M. Kingswood was lead-left underwriter. Hunter Taubman Fischer & Li, Conyers Dill & Pearman and Guantao Law Firm advised the company and VCL Law and Jincheng Tongda & Neal advised the underwriters.

Status

IPO

Ticker

ZYBT

Exchange

Nasdaq

Priced

Jan 7, 2025

IPO price

$4.00

Price range

$4.00–$5.00

Raised

$6M

Market cap at IPO price

$188.7M

First filed

Jan 9, 2024

Underwriters

Kingswood

Company counsel

Hunter Taubman Fischer & Li, Conyers Dill & Pearman and Guantao Law Firm

Underwriters' counsel

VCL Law and Jincheng Tongda & Neal

Sector

Biotech & pharma

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.